Concepedia

Publication | Open Access

Prediction of response and survival after standardized treatment with 7400 MBq 177Lu-PSMA-617 every 4 weeks in patients with metastatic castration-resistant prostate cancer

DOIFull Paper Access

35

Citations

22

References

2020

Year

Sazan Rasul, Markus Hartenbach, Tim Wollenweber, Elisabeth Kretschmer‐Chott, Bernhard Grubmüller, Gero Kramer, Shahrokh F. Shariat, Wolfgang Wadsak, Markus Mitterhauser, Verena Pichler,
European Journal of Nuclear Medicine and Molecular Imaging

Abstract

Basal Hb level is an independent predictor for therapy response and survival in patients receiving PSMA-RLT every 4 weeks. Both baseline PSA ≤ 650 μg/L and normal Hb levels were associated with longer survival.

References

YearCitations

Page 1